9 Reasons Inositol Is Worth Knowing About in Perimenopause
When the weight started creeping up despite eating the same way as always, and the anxiety started spiking at 3am for no clear reason, nobody mentioned insulin resistance as a possible thread connecting all of it. Finding out that something as unglamorous as inositol could sit right at that intersection felt like finally being handed the right map.
Learn more about Rose →It sits at the heart of insulin signalling
Inositol — particularly myo-inositol — acts as a secondary messenger inside cells, helping insulin do its job of shuttling glucose out of the bloodstream. When insulin signalling is sluggish, blood sugar climbs and fat storage increases, especially around the abdomen. This is exactly the mechanism that becomes strained during perimenopause as oestrogen levels fall and insulin sensitivity naturally declines.
Women with PCOS history may feel the benefit most
PCOS is fundamentally a condition of insulin resistance and androgen excess, and myo-inositol has the strongest evidence base precisely in this population. Since PCOS and perimenopause share overlapping metabolic disruption — rising androgens, falling oestrogen, worsening insulin sensitivity — women who already know their body trends this way may find inositol particularly relevant in their forties. Several RCTs have shown improvements in fasting insulin and androgen markers in women with PCOS taking myo-inositol.
It may help smooth out blood sugar swings that drive fatigue
Erratic blood sugar — highs followed by sharp drops — is a common but underrecognised driver of the bone-deep fatigue many perimenopausal women describe. By improving insulin receptor sensitivity at the cellular level, myo-inositol can help flatten those curves, leading to more stable energy across the day. This effect is distinct from stimulants and works with the body's own metabolic machinery rather than around it.
There's a meaningful anxiety connection via the brain
Inositol was studied in the 1990s as a direct treatment for panic disorder and anxiety, with some trials showing effects comparable to SSRIs in specific anxiety conditions. It acts on serotonin receptor pathways in the brain, which rely on inositol phosphate signalling to function properly. For perimenopausal women whose anxiety has emerged or worsened alongside hormonal shifts, this neurological angle makes inositol worth knowing about — even if the evidence is not yet definitive for this specific population.
It may support ovarian function in the final fertile years
Myo-inositol is highly concentrated in ovarian follicular fluid, where it supports egg quality and follicle development. As ovarian reserve diminishes through perimenopause, the follicular environment matters more, not less, for cycle regularity and hormone production. Research in assisted reproduction has shown inositol supplementation improves oocyte quality, suggesting it plays a structural role in ovarian health that doesn't simply switch off before menopause.
The myo-inositol and D-chiro-inositol ratio matters
The body uses two main forms of inositol — myo-inositol and D-chiro-inositol — in different tissues and at different ratios. In the ovary, the ideal ratio is approximately 40:1 myo to D-chiro; disrupting this ratio, as happens with insulin resistance, impairs follicle function. Research suggests supplementing with myo-inositol alone, or in the 40:1 ratio combination, is more effective than D-chiro-inositol alone, which can paradoxically worsen outcomes at higher doses.
It may take some of the edge off mood instability
Beyond anxiety specifically, inositol's role in phospholipid signalling touches the same pathways disrupted by falling oestrogen — including those governing serotonin and dopamine receptor sensitivity. Some observational data and smaller trials suggest mood stabilisation effects, particularly in women with a premenstrual history of mood dysregulation, which is itself a predictor of more difficult perimenopause mood symptoms. The mechanism is plausible and the safety profile is good, which makes it a reasonable consideration while stronger evidence accumulates.
It's generally well tolerated at research doses
Most clinical trials have used doses of 2g to 4g of myo-inositol daily, and side effects are typically mild and gastrointestinal — nausea or loose stools at higher doses, usually resolving with food or dose reduction. Unlike many supplements studied in women's health, inositol has no known interaction with common perimenopause medications and is not contraindicated alongside HRT. This tolerability profile is part of why it warrants attention as an adjunct strategy rather than an either/or choice.
It's a naturally occurring compound, not a synthetic intervention
Inositol is present in beans, wholegrains, nuts, and citrus fruit, and is synthesised in the body from glucose — meaning it's a nutrient the body already knows how to use. Supplementation essentially tops up a compound that modern diets and metabolic stress may deplete, rather than introducing something foreign to the system. For women who want to address perimenopause metabolic changes with a lighter-touch approach before or alongside other interventions, this positions inositol as a genuinely low-barrier starting point.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.